WIMI Hologram Academy: Human Action Simulation System Based on Virtual Reality Technology

3 years ago

HONG KONG, July 05, 2022 (GLOBE NEWSWIRE) -- WIMI Hologram Academy, working in partnership with the Holographic Science Innovation Center, has…

Exagen Releases Largest Comparative Utility Study in Lupus Diagnostics Confirming AVISE® Lupus Delivers Unparalleled Utility

3 years ago

SAN DIEGO, July 05, 2022 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, announced new robust,…

Outlook Therapeutics Announces Full Cash Pre-Payment of Convertible Promissory Note

3 years ago

ISELIN, N.J., July 05, 2022 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a pre-commercial biopharmaceutical company working to develop and…

OrthoPediatrics Corp. Completes Acquisition of Pega Medical

3 years ago

WARSAW, Ind., July 05, 2022 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively…

Top International Academic Institutions Complete Independent Studies Validating C-POLAR™ Technology

3 years ago

Independent data verification at Hong Kong Metropolitan University, the Czech Academy of Sciences, Finland’s Tampere University, Massachusetts General Hospital, Harvard…

Inspire Medical Systems, Inc. to Report Second Quarter 2022 Financial Results on August 2, 2022

3 years ago

MINNEAPOLIS, July 05, 2022 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the…

Alignment Healthcare Welcomes Randall Fitzpatrick, Formerly of Optum, as Senior Vice President of Product

3 years ago

ORANGE, Calif., July 05, 2022 (GLOBE NEWSWIRE) -- Alignment Healthcare (NASDAQ: ALHC), a tech-enabled Medicare Advantage company, today announced that…

Orchestra BioMed™ Announces Strategic Collaboration, Closing of $110 Million Private Equity Financing and Plans to List on Nasdaq Through Merger with Health Sciences Acquisitions Corporation 2

3 years ago

      Strategic collaboration with Medtronic to develop BackBeat Cardiac Neuromodulation Therapy™ as potential integrated hypertension treatment for cardiac pacemaker…

89bio Announces Closing of its Upsized $94.5 Million Public Offering of Common Stock, Pre-Funded Warrants and Warrants

3 years ago

SAN FRANCISCO, July 05, 2022 (GLOBE NEWSWIRE) -- 89bio, Inc. (“89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the…

Ayala Pharmaceuticals Announces Interim Data from Part A of the Phase 2/3 RINGSIDE Trial of AL102 in Desmoid Tumors

3 years ago

- Tumor shrinking observed in substantially all patients who were evaluable at 16 weeks - - Favorable safety results observed:…